====== Antibiogram ======
Generated by [[https://www.openevidence.com/ |OpenEvidence.com]] 27Jun2025

^ Organism                 ^ Antibiotic               ^ % Susceptible (Range)  ^ Notes (if any)                             ^
| Staphylococcus aureus    | Oxacillin (Methicillin)  | ~58–62                 | MRSA prevalence varies by region           |
|                          | Vancomycin               | 100                    | No resistance detected in recent surveys   |
|                          | Clindamycin              | ~20                    | High resistance in some settings           |
|                          | Erythromycin             | ~10–20                 | High resistance                            |
|                          | Linezolid                | 100                    | No resistance detected                     |
| Escherichia coli         | Ampicillin               | ~10–44                 | High resistance                            |
|                          | Ceftriaxone              | ~60–90                 | ESBL rates affect susceptibility           |
|                          | Ciprofloxacin            | ~70–95                 | Lower in inpatient settings                |
|                          | Nitrofurantoin           | ~87                    | Good for urinary isolates                  |
|                          | Imipenem/Meropenem       | >95                    | Carbapenem resistance rare but increasing  |
| Klebsiella pneumoniae    | Ampicillin               | 0                      | Intrinsic resistance                       |
|                          | Ceftriaxone              | ~50–90                 | ESBL rates variable                        |
|                          | Ciprofloxacin            | ~60–90                 | Variable by region                         |
|                          | Imipenem/Meropenem       | ~50–95                 | Carbapenemase-producers increasing         |
| Pseudomonas aeruginosa   | Piperacillin-tazobactam  | ~93                    | Resistance <10% in most settings           |
|                          | Ceftazidime              | ~93                    | Resistance <10%                            |
|                          | Ciprofloxacin            | ~80–94                 | Lower in inpatient settings                |
|                          | Amikacin                 | ~98                    | High susceptibility                        |
| Enterococcus faecalis    | Ampicillin               | 100                    | High-level gentamicin resistance ~43%      |
|                          | Vancomycin               | ~97                    | VRE rare but present                       |
|                          | Linezolid                | 100                    | No resistance detected                     |
| Proteus mirabilis        | Nitrofurantoin           | 0                      | Intrinsic resistance                       |
|                          | Ceftriaxone              | ~20–90                 | Variable resistance                        |
| Acinetobacter baumannii  | Carbapenems              | <10                    | High resistance in ICU settings            |